Discovery Park Ventures
Overview
Discovery Park Ventures is an early-stage investment fund that invests in ambitious and growing life sciences companies with a focus on novel and disruptive technologies related to advanced manufacturing, digital and AI, cell and gene therapies, and neurology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oxford Medical Products | Apr 2023 | VC Round | Co-investor |
| BoobyBiome | Sep 2022 | Pre Seed | Co-investor |
| Vitarka Therapeutics | May 2022 | Seed | Lead |
| Vox Imaging Technology Ltd | Nov 2023 | Seed | Lead |
| RevoNA Bio | - | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Discovery Park Ventures based?
Discovery Park Ventures is headquartered in Sandwich, United Kingdom.
When was Discovery Park Ventures founded?
Discovery Park Ventures was founded in 2022.
How many portfolio companies does Discovery Park Ventures have?
Discovery Park Ventures has 8 portfolio companies in Caplight's dataset.
What are some companies in Discovery Park Ventures's portfolio?
Portfolio companies visible on Caplight include Oxford Medical Products, BoobyBiome, Vitarka Therapeutics, Vox Imaging Technology Ltd, RevoNA Bio.
What was Discovery Park Ventures's most recent investment shown here?
Discovery Park Ventures's most recent investment in this portfolio sample was in Vox Imaging Technology Ltd in 2023.
What sectors does Discovery Park Ventures focus on?
Discovery Park Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Discovery Park Ventures focus on?
Discovery Park Ventures typically invests at the Early stage.
What is Discovery Park Ventures's AUM?
Discovery Park Ventures's assets under management are estimated between $3.8M and $3.8M.